Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptation, Psychological | 19 | 2022 | 243 | 2.180 |
Why?
|
| Quality of Life | 20 | 2022 | 924 | 2.020 |
Why?
|
| Neoplasms | 19 | 2022 | 1322 | 2.010 |
Why?
|
| Cystic Fibrosis | 3 | 2021 | 157 | 1.810 |
Why?
|
| Depression | 11 | 2021 | 596 | 1.810 |
Why?
|
| Spirituality | 9 | 2022 | 30 | 1.550 |
Why?
|
| Attitude to Health | 6 | 2018 | 226 | 1.430 |
Why?
|
| Religion and Medicine | 6 | 2015 | 23 | 1.410 |
Why?
|
| Pandemics | 2 | 2021 | 594 | 1.070 |
Why?
|
| Mental Health | 4 | 2020 | 245 | 0.890 |
Why?
|
| Psychotherapy, Group | 4 | 2007 | 24 | 0.860 |
Why?
|
| Social Support | 7 | 2019 | 297 | 0.840 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2011 | 583 | 0.840 |
Why?
|
| Stem Cell Transplantation | 3 | 2008 | 201 | 0.770 |
Why?
|
| Religion and Psychology | 5 | 2016 | 27 | 0.760 |
Why?
|
| Head and Neck Neoplasms | 5 | 2021 | 336 | 0.740 |
Why?
|
| Self Efficacy | 2 | 2019 | 137 | 0.730 |
Why?
|
| Sick Role | 2 | 2011 | 14 | 0.730 |
Why?
|
| Airway Management | 1 | 2019 | 22 | 0.680 |
Why?
|
| Transplantation, Autologous | 5 | 2009 | 485 | 0.650 |
Why?
|
| Anxiety | 5 | 2021 | 279 | 0.630 |
Why?
|
| Patients | 1 | 2018 | 53 | 0.630 |
Why?
|
| Terminal Care | 1 | 2018 | 55 | 0.620 |
Why?
|
| Patient Compliance | 1 | 2019 | 247 | 0.610 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 184 | 0.590 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.580 |
Why?
|
| Health Behavior | 1 | 2019 | 275 | 0.580 |
Why?
|
| Mental Disorders | 2 | 2020 | 445 | 0.580 |
Why?
|
| Middle Aged | 21 | 2020 | 13082 | 0.550 |
Why?
|
| Health Status | 5 | 2015 | 368 | 0.520 |
Why?
|
| Humans | 43 | 2022 | 54391 | 0.490 |
Why?
|
| Breast Neoplasms | 3 | 2010 | 1249 | 0.480 |
Why?
|
| Adult | 15 | 2021 | 14207 | 0.460 |
Why?
|
| Female | 25 | 2022 | 28471 | 0.450 |
Why?
|
| Multiple Myeloma | 5 | 2009 | 3049 | 0.410 |
Why?
|
| Treatment Outcome | 12 | 2020 | 5612 | 0.400 |
Why?
|
| HIV Infections | 3 | 2004 | 394 | 0.400 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 41 | 0.390 |
Why?
|
| Survivors | 2 | 2020 | 137 | 0.390 |
Why?
|
| Male | 20 | 2020 | 27347 | 0.370 |
Why?
|
| Stress, Psychological | 5 | 2015 | 270 | 0.360 |
Why?
|
| Aged | 12 | 2020 | 10060 | 0.340 |
Why?
|
| Sleep | 1 | 2010 | 188 | 0.340 |
Why?
|
| Medical Oncology | 2 | 2008 | 110 | 0.330 |
Why?
|
| Self-Help Groups | 1 | 2008 | 16 | 0.320 |
Why?
|
| Melphalan | 1 | 2009 | 184 | 0.320 |
Why?
|
| Primary Health Care | 1 | 2011 | 398 | 0.310 |
Why?
|
| Culture | 1 | 2008 | 58 | 0.310 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 742 | 0.310 |
Why?
|
| Prevalence | 4 | 2020 | 1025 | 0.300 |
Why?
|
| Biomedical Research | 1 | 2010 | 241 | 0.290 |
Why?
|
| Religion | 2 | 2016 | 68 | 0.290 |
Why?
|
| Choice Behavior | 1 | 2007 | 95 | 0.280 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1696 | 0.270 |
Why?
|
| Occupational Diseases | 1 | 2006 | 93 | 0.250 |
Why?
|
| Aging | 1 | 2010 | 784 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 331 | 0.240 |
Why?
|
| Pituitary-Adrenal System | 1 | 2004 | 23 | 0.240 |
Why?
|
| Health Facilities | 1 | 2004 | 43 | 0.240 |
Why?
|
| HIV Seropositivity | 1 | 2004 | 28 | 0.240 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2004 | 28 | 0.240 |
Why?
|
| Health Personnel | 2 | 2006 | 247 | 0.240 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 106 | 0.230 |
Why?
|
| Rural Population | 1 | 2008 | 598 | 0.220 |
Why?
|
| Interpersonal Relations | 2 | 2015 | 115 | 0.220 |
Why?
|
| Arkansas | 3 | 2020 | 2100 | 0.210 |
Why?
|
| Critical Illness | 1 | 2005 | 344 | 0.210 |
Why?
|
| Cognition | 5 | 2015 | 350 | 0.210 |
Why?
|
| Christianity | 1 | 2001 | 5 | 0.210 |
Why?
|
| Patient-Centered Care | 1 | 2003 | 132 | 0.210 |
Why?
|
| Patient Care Team | 1 | 2003 | 273 | 0.200 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1300 | 0.200 |
Why?
|
| Deglutition | 1 | 2021 | 37 | 0.200 |
Why?
|
| Disease Progression | 2 | 2019 | 915 | 0.190 |
Why?
|
| Risk Factors | 3 | 2020 | 3937 | 0.190 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 47 | 0.170 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 98 | 0.170 |
Why?
|
| Behavior | 2 | 2015 | 48 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 259 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2018 | 326 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 3431 | 0.140 |
Why?
|
| Caregivers | 2 | 2010 | 241 | 0.140 |
Why?
|
| Pain | 2 | 2009 | 405 | 0.120 |
Why?
|
| Social Desirability | 1 | 2011 | 2 | 0.100 |
Why?
|
| Combined Modality Therapy | 4 | 2019 | 693 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 385 | 0.100 |
Why?
|
| Affective Symptoms | 1 | 2010 | 22 | 0.090 |
Why?
|
| Grief | 1 | 2010 | 9 | 0.090 |
Why?
|
| Psychological Theory | 1 | 2010 | 25 | 0.090 |
Why?
|
| Health | 1 | 2010 | 28 | 0.090 |
Why?
|
| Age Factors | 2 | 2014 | 1199 | 0.090 |
Why?
|
| Affect | 1 | 2010 | 104 | 0.090 |
Why?
|
| Cancer Care Facilities | 1 | 2009 | 21 | 0.090 |
Why?
|
| Comorbidity | 1 | 2011 | 664 | 0.090 |
Why?
|
| United States | 2 | 2019 | 5208 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2009 | 30 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 639 | 0.080 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2008 | 1 | 0.080 |
Why?
|
| Ethics Committees, Research | 1 | 2008 | 18 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2019 | 2606 | 0.080 |
Why?
|
| Hematology | 1 | 2008 | 26 | 0.080 |
Why?
|
| Psychology | 1 | 2007 | 30 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2008 | 445 | 0.080 |
Why?
|
| Demography | 1 | 2007 | 103 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2008 | 259 | 0.070 |
Why?
|
| Europe | 2 | 2019 | 102 | 0.070 |
Why?
|
| Motivation | 1 | 2009 | 289 | 0.070 |
Why?
|
| Health Services Accessibility | 2 | 2008 | 428 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2009 | 311 | 0.070 |
Why?
|
| Burnout, Professional | 1 | 2006 | 57 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2004 | 232 | 0.060 |
Why?
|
| Laryngeal Neoplasms | 1 | 2004 | 55 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 541 | 0.060 |
Why?
|
| Pain Management | 1 | 2004 | 155 | 0.060 |
Why?
|
| Data Collection | 1 | 2004 | 320 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 276 | 0.050 |
Why?
|
| Negativism | 1 | 2001 | 3 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 375 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2004 | 325 | 0.050 |
Why?
|
| Self Concept | 1 | 2001 | 71 | 0.050 |
Why?
|
| Mass Screening | 1 | 2004 | 370 | 0.050 |
Why?
|
| Pediatrics | 1 | 2004 | 323 | 0.050 |
Why?
|
| Family | 1 | 2001 | 191 | 0.050 |
Why?
|
| India | 2 | 2010 | 81 | 0.040 |
Why?
|
| Communication | 1 | 2001 | 265 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 2390 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 128 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2001 | 1229 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1060 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 643 | 0.040 |
Why?
|
| Psychometrics | 1 | 2019 | 239 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 922 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 594 | 0.030 |
Why?
|
| Spiritual Therapies | 1 | 2015 | 6 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1301 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 35 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2014 | 94 | 0.030 |
Why?
|
| Palliative Care | 1 | 2015 | 188 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2014 | 195 | 0.030 |
Why?
|
| Adolescent | 1 | 2004 | 6900 | 0.030 |
Why?
|
| Sex Factors | 1 | 2014 | 766 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 128 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 807 | 0.030 |
Why?
|
| Child | 1 | 2004 | 7368 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 1362 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2009 | 89 | 0.020 |
Why?
|
| Time Management | 1 | 2009 | 8 | 0.020 |
Why?
|
| Informed Consent | 1 | 2008 | 92 | 0.020 |
Why?
|
| Health Education | 1 | 2009 | 178 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 117 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2008 | 379 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 311 | 0.020 |
Why?
|
| Financing, Organized | 1 | 2004 | 14 | 0.020 |
Why?
|
| Laryngectomy | 1 | 2004 | 28 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2004 | 47 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2004 | 61 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2008 | 6459 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2004 | 140 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2004 | 308 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 351 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 3210 | 0.010 |
Why?
|